1. Home
  2. ASPN vs NVAX Comparison

ASPN vs NVAX Comparison

Compare ASPN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • NVAX
  • Stock Information
  • Founded
  • ASPN 2001
  • NVAX 1987
  • Country
  • ASPN United States
  • NVAX United States
  • Employees
  • ASPN N/A
  • NVAX N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASPN Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • ASPN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • ASPN 1.5B
  • NVAX 2.0B
  • IPO Year
  • ASPN 2014
  • NVAX 1995
  • Fundamental
  • Price
  • ASPN $18.18
  • NVAX $9.76
  • Analyst Decision
  • ASPN Strong Buy
  • NVAX Buy
  • Analyst Count
  • ASPN 9
  • NVAX 6
  • Target Price
  • ASPN $32.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • ASPN 3.0M
  • NVAX 7.2M
  • Earning Date
  • ASPN 11-06-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • ASPN N/A
  • NVAX N/A
  • EPS Growth
  • ASPN N/A
  • NVAX N/A
  • EPS
  • ASPN 0.02
  • NVAX N/A
  • Revenue
  • ASPN $357,245,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • ASPN $72.06
  • NVAX N/A
  • Revenue Next Year
  • ASPN $30.15
  • NVAX N/A
  • P/E Ratio
  • ASPN $954.90
  • NVAX N/A
  • Revenue Growth
  • ASPN 87.96
  • NVAX N/A
  • 52 Week Low
  • ASPN $7.37
  • NVAX $3.53
  • 52 Week High
  • ASPN $33.15
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 32.60
  • NVAX 36.20
  • Support Level
  • ASPN $18.95
  • NVAX $9.52
  • Resistance Level
  • ASPN $20.19
  • NVAX $10.63
  • Average True Range (ATR)
  • ASPN 1.47
  • NVAX 0.57
  • MACD
  • ASPN -0.39
  • NVAX -0.12
  • Stochastic Oscillator
  • ASPN 3.31
  • NVAX 9.97

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: